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Abstract
Background: Legionella pneumophila (LPN) can cause a lethal infectious disease with a marked inflammatory
response in humans. However, the mechanism of this severe inflammation remains poorly understood. Since
necrosis is known to induce inflammation, we investigated whether LPN induces necrosis in macrophages. We also
analyzed the involvement of lysosomal cathepsin B in LPN-induced cell death.
Methods: The human monocytic cell line THP-1 was infected with LPN, NUL1 strain. MG132-treated cells were
used as apoptotic control cells. After infection, the type of cell death was analyzed by using microscopy, LDH
release and flow cytometry. As a proinflammatory mediator, high-mobility group box 1 (HMGB-1), was measured.
Cathepsin B activity was also measured and the inhibitory effects of cathepsin B on LPN-induced cell death were
analyzed.
Results: THP-1 cells after treatment with high dose of LPN showed necrotic features with releasing HMGB-1. This
necrosis and the HMGB-1 release were inhibited by a specific lysosomal cathepsin B inhibitor and were
characterized by a rapid and high activation of cathepsin B that was not observed in apoptotic control cells. The
necrosis was also accompanied by cathepsin B-dependent poly(ADP-ribose) polymerase (PARP) cleavage.
Conclusions: We demonstrate here that L. pneumophila rapidly induces cathepsin B-dependent necrosis in a dose-
dependent manner and releases a proinflammatory mediator, HMGB-1, from macrophages. This report describes a
novel aspect of the pathogenesis of Legionnaires’ disease and provides a possible therapeutic target for the
regulation of inflammation.
Introduction
Legionella pneumophila is an intracellular pathogen that
causes rapidly advancing pneumonia and is sometimes
life-threatening. After inhalation into the lung, the
organism initially infects alveolar macrophages and
replicates in these cells. The infected macrophages pro-
duce cytokines such as IL-b and TNF-a that activate
both themselves and other immune cells [1]. However,
although the functions of macrophages in response to
this pathogen are crucial for innate immunity, the
mechanism by which this pathogen induces such a
severe immune response is not well understood.
In infectious diseases, cell death that occurs as a result
of interactions between the infectious organism and the
host cell can have important implications for host
defense or bacterial survival. Apoptosis is a typical pro-
grammed cell death that is tightly regulated by various
proteases, requires ATP and does not involve inflamma-
tion [2]. In contrast, necrosis, a type of cell death that is
accompanied by inflammation, has been considered to
represent accidental cell death due to exposure to supra-
physiological conditions such as mechanical trauma,
heat or cold [3]. During interactions between pathogens
such as Shigella [4], Salmonella [5] and Mycobacterium
tuberculosis [6] and the host immune response, there
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bacteria that appears to have features of necrosis. While
L. pneumophila has been shown to induce apoptosis in
macrophages or monocytic cell lines when the cells
were infected at a low dose of bacteria [7-9], induction
of apoptosis is not necessarily associated with pathogen-
esis in severe infections. Thus, necrosis can contribute
to inflammation in Legionnaires’ disease, although there
are few reports concerning the induction of necrosis by
L. pneumophila, in which a high dose of bacteria was
used [10,11].
Recent research has implicated lysosomal function in
cell death [12]. Many types of proteases and chemical
agents that are known apoptosis inducers, such as cas-
pases, anticancer agents and reactive oxygen species,
may also be involved in cell death via the modulation of
lysosomal membrane permeability, and some of these
agents also induce necrosis [13]. Similarly, it has been
shown that necrosis, like apoptosis, can be regulated by
intracellular molecules, and lysosomes in particular are
considered to be important organelles for programmed
necrosis [13,14].
In this report, we determined if L. pneumophila
induces necrotic cell death in a monocytic cell line and
in murine macrophages by comparing cell death
induced by L. pneumophila with that induced by an
apoptotic agent. We also examined the role of lysosomal
enzymes in L. pneumophila-induced cell death. We
found that potent activation of cathepsin B leads to
necrosis accompanied by inflammation in cells infected
with a high dose of L. pneumophila. In addition, cell
death and inflammation were inhibited by attenuation of
cathepsin B.
Materials and methods
Reagents
PARP antibody was from Cell Signaling Technology
(Danvers, MA) and anti-cathepsin B antibody (CA10)
was from Abcam (Cambridge, MA). CA074Me and
zVADfmk were obtained from the Peptide institute
(Osaka, Japan).
Bacterial strains
The L. pneumophila NUL1 bacterial strain, serogroup 1,
which was clinically isolated from the sputum of a
patient at Nagasaki University Hospital [15], was used.
The bacteria were cultured on buffered charcoal yeast
extract a agar plates for 3 days. The bacteria were
stored at -80°C in a Microbank system (Pro-Lab Diag-
nostics, Ontario, Canada) until use.
Animals
Female A/J mice, 6-8-weeks old, were purchased from
J a p a nS L C ,I n c .( S h i z u o k a ,J a p a n ) .A l la n i m a l sw e r e
housed in a pathogen-free environment and received
sterile food and water in the Laboratory Animal Center
for Biomedical Science at Nagasaki University. Animal
care and experimental procedures were performed in
accordance with the Guidelines for Animal Experimen-
tation of Nagasaki University with approval of the Insti-
tutional Animal Care and Use Committee.
Cell lines and treatment procedure
The human monocytic cell line THP-1 was cultured in
RPMI1640 medium containing 10% FBS. Murine alveo-
lar or peritoneal macrophages were obtained from
bronchoalveolar lavage fluid or peritoneal lavage fluid
3 days after injection of 4% thioglycollate into the peri-
toneum, respectively. The cells were plated into 96-well
plates at a density of 1 × 10
5 cells/well for all experi-
ments except for fluorescent microscopy. After addition
of L. pneumophila or MG132, the plate was centrifuged
at 1000 × g for 5 min. For inhibition studies, the cells
were pre-treated with CA074Me for 30 min before
stimulation.
Cytotoxicity assay
Cell death was evaluated using a cytotoxicity detection
kit (Roche Diagnostics GmbH, Mannheim, Germany)
based on the measurement of LDH according to the
manufacturer’s instructions. To determine cytotoxicity,
the value of samples from 1% Triton-X-treated cells was
defined as 100% cell death.
Optical microscopy
Cells were stained with 0.2% trypan blue and trypan
blue-positive and -negative cells were counted. To
observe morphological findings, the cells were centri-
f u g e da t1 , 0 0 0×g for 1 min, fixed onto slides and were
then stained with Diff-Quik (Sysmex, Hyogo, Japan).
Cellular morphological features were categorized by two
cytologists. One hundred cells were counted three times
and the results are presented as an average value.
Fluorescent microscopy
Mice macrophages were plated into a CultureWell cham-
bered coverglass (Life Technologies, Carlsbad, CA) at a
density of 1 × 10
3 cells/well (alveolar macrophages) or 1 ×
10
5 cells/well (peritoneal macrophages) and were cultured
in fresh medium overnight. After treatment, the cells were
incubated with PBS containing 7.5 μg/mL Hoechst 33342
and 2 μg/mL PI for 30 min. The preparation was observed
using a Leica DM400B fluorescent microscope (Leica
Microsystems GmbH, Wetzlar, Germany).
Cathepsin B activity
Cells were washed and homogenized at 4°C in lysis buf-
fer as described previously [16]. Cell lysates (10 μg)
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Institute. Inc., Osaka, Japan) at 37°C for 2 h and the
release of amino-4-methylcoumarin (AMC) was moni-
tored using a SPECTRA Flour microplate reader (Tecan
Japan Co., Ltd., Kanagawa, Japan). All experiments were
performed in duplicate.
Flow cytometry
To evaluate cell death changes, cells were simultaneously
stained with FITC-conjugated Annexin-V and the non-vital
dye PI (Bender Medsystems, Vienna, Austria) to enable dis-
crimination of intact cells (Annexin-V
-,P I
-), early apoptotic
cells (Annexin-V
+,PI
-) and late apoptotic or necrotic cells
(Annexin-V
+,P I
+). Cells were harvested after treatment,
and 10
4 cells per sample were analyzed using a FACSCali-
bur flow cytometer and CellQuest software (BD Biosciences
Immunocytometry Systems, San Jose, CA).
Western blotting
Cells were harvested after treatment, and were washed
and homogenized at 4°C in RIPA buffer. Cell lysates
(20-50 μg) were resolved by electrophoresis on a 12.5%
polyacrylamide gel, and were transferred to a polyvinyli-
dine difluoride membrane. After blocking the membrane
in 10% FBS and 0.1% Tween-20 in Tris-buffered saline
for 1 h at room temperature, blots were hybridized with
primary antibodies overnight at 4°C. After hybridization
with a secondary antibody, the immunocomplexes were
visualized using an ECL Western Blotting Detection Sys-
tem (GE Healthcare, Chalfont St. Giles, UK).
HMGB-1 concentration
The concentration of extracellular HMGB-1 was mea-
sured using an HMGB-1 ELISA Kit II (Shino Test,
Kanagawa, Japan) according to the manufacturer’s
instructions. Briefly, 10 μL of samples were added to an
anti-HMBG-1 antibody-coated plate. After incubation at
37°C for 24 h, the plate was incubated with peroxidase-
conjugated anti-HMGB-1 monoclonal antibody for 2 h
at room temperature. Color was developed using a
3,3’,5,5’-tetramethylbenzidine and peroxidase solution.
Absorbance was read at 450 nm.
Statistical analysis
Cytotoxicity, morphological classification and HMGB-1
concentrations were expressed as means ± SD. One-way
analysis of variance was used to determine statistically
significant differences between groups. Tukey’st e s tw a s
used to confirm differences between individual groups.
Results
A High dose of L. pneumophila induces necrotic cell death
The levels of L. pneumophila used were calculated based
on the ratio of bacteria to cells, and are expressed as
multiplicity of infection (MOI). First, we assayed the
time course of lactate dehydrogenase (LDH) release into
the culture medium following incubation of THP-1 cells
with various levels of L. pneumophila (Figure 1A).
L. pneumophila increased the levels of LDH, as well as
the percentage of trypan blue-positive cells (data not
shown), in a dose- and time-dependent manner but not
an apoptosis inducer, MG132 [17] (Figure 1B). Follow-
ing 6 h of incubation with an MOI 500 of L. pneumo-
phila, the cells showed characteristic features that are
consistent with necrosis such as the loss of plasma
membrane integrity and irregular and poorly-stained
nuclei in contrast to MG132-treated apoptotic cells (Fig-
ure 1C). The necrotic cells partially appeared even when
cells were infected by a low dose of bacteria, and the
necrotic cells increased in a dose-dependent manner
with addition of L. pneumophila (Figure 1D). Thus, an
MOI 500 of bacteria was used in subsequent experi-
ments to analyze the character of L. pneumophila-
induced necrotic cells. In flow cytometry analysis with
Annexin-V and PI binding, L. pneumophila-treated cells
were divided into two clusters over time of treatment
(Figure 1E). The cells in one group rapidly transformed
into cells that were double-positive for Annexin-V and
PI that represented 30.5% of the total population at 2 h.
The second group of cells began to appear as Annexin-
V-positive and PI-negative cells at 2 h and some of
these cells were observed as double-positive cells at 6 h.
High mobility group box 1 (HMGB-1), known as a
necrotic marker as well as a proinflammatory molecule,
was also significantly increased in the culture medium
after L. pneumophila stimulation (Figure 1F). These sug-
gest that a high dose of L. pneumophila induces necrotic
cell death.
L. pneumophila-induced necrotic cell death is dependent
on cathepsin B
To examine the involvement of cathepsin B in L. pneu-
mophila-induced necrotic cell death, we assayed the cel-
lular level of pro-cathepsin B. The level of pro-cathepsin
B gradually diminished over time following infection,
suggesting its processing into an active enzyme (Figure
2A). Pre-treatment with a specific cathepsin B inhibitor,
CA074Me, at a concentration of 50 or 100 μM
decreased L. pneumophila-induced LDH by about 50%
(Figure 2B). Thus, we used CA074Me at a concentration
of 100 μM in subsequent inhibitory experiments. This
concentration of CA074Me alone did not affect all of
the parameters in this study and bacterial growth.
Microscopic observation clearly indicated fewer necrotic
cells after CA074Me pretreatment than non-treated cells
(Figure 2C). Instead, the number of intact cells, which
had maintained a plasma membrane and a normally
stained and shaped nucleus, and apoptotic cells seemed
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cantly suppressed by CA074Me pretreatment compared
to L. pneumophila stimulation alone (Figure 2D). These
findings were also observed in the assay with another
isolate (data not shown). These suggest that L. pneumo-
phila-induced necrotic cell death is dependent on cathe-
psin B.
Cathepsin B regulates both necrotic and apoptotic cell
death
Next, the effect of CA074Me on the type of cell was ana-
lyzed. CA074Me pretreatment decreased the percentage
of necrotic cells to 50% or lower than that of non-treated
cells (Figure 3A). Annexin-V- and PI-double-positive
cells decreased and that the intact double-negative cells
increased (Figure 3B). In MG132-treated cells, CA074Me
pretreatment slightly suppressed the percentage of apop-
totic cells (Figure 3C) and this effect was more clearly
observed in flow cytometry (Figure 3D). These results
indicated that cathepsin B is involved in the induction of
both necrotic and apoptotic cell death.
L. pneumophila-induced high activation of cathepsin B is
involved in poly(ADP-ribose) polymerase (PARP) cleavage
and cell death
To analyze the different functions of cathepsin B on cell
death, we examined the time course of cathepsin B acti-
vation. Interestingly, L. pneumophila induced a rapid
peak of cathepsin B activity that occurred within 2 h
and subsequently dropped to approximately half of the
peak value, whereas MG132 treatment induced a gra-
dual elevation (Figure 4A). The high cathepsin B activa-
tion was also observed in other experiments within 6 h.
CA074Me almost completely inhibited the activation of
cathepsin B (data not shown). Next, we examined the
cleavage of PARP at 2 h with using CA074ME or a pan-
caspase inhibitor, zVADfmk (Figure 4B) because PARP
cleavage can be observed in necrosis [18] and apoptosis
Figure 1 A high dose of L. pneumophila induces necrotic cell death in THP-1 cells. (A) Cytotoxicity of L. pneumophila was evaluated by
assay of LDH release from THP-1 cells. (B) LDH release after 6h-stimulation with an MOI 500 of L. pneumophila or 10 μM of the apoptotic
inducer MG132. (C) Diff-Quik staining after 6h-stimulation with an MOI 500 of L. pneumophila or MG132. L. pneumophila induced necrotic
features such as loss of plasma membrane integrity and irregular and poorly-stained nuclei. The scale bar represents 20 μm. (D) Microscopic
findings of the three cell groups identified following 6 h stimulation. L. pneumophila increased the percentage of necrotic cells in a dose-
dependent manner. In contrast, MG132 induced mainly apoptotic cells. (E) Flow cytometric analysis of THP-1 cells, infected with an MOI of 500
of L. pneumophila, and stained with Annexin-V and PI. The number at the bottom of each panel indicates the percentage of cells detected in
that area. (F) Extracellular HMGB-1 after 6 h incubation following infection with an MOI of 500 of L. pneumophila, or with MG132. HMGB-1 was
significantly increased by L. pneumophila but not by MG132. Values are expressed as means ± SD. ** indicates p < 0.01.
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of cleaved PARP compared to MG132 and this enhance-
ment was attenuated more strongly by CA074Me than
by zVADfmk. L. pneumophila-induced LDH was also
significantly suppressed by pretreatment with CA074Me
but not by pretreatment with zVADfmk (Figure 3C).
These results suggest that L. pneumophila induces cas-
pase-independent but cathepsin B-dependent PARP
cleavage and cell death.
Cathepsin B is involved in L. pneumophila-induced murine
macrophage death
We examined whether the cathepsin B-mediated, L.
pneumophila-induced cell death also occurs in murine
macrophages. A/J mouse alveolar or peritoneal macro-
phages were stained with PI, which serves as a marker
of plasma membrane permeability (Figure 5A). Most of
the alveolar macrophages were PI-positive after stimula-
tion with L. pneumophila. However, pretreatment with
CA074Me markedly reduced the number of PI-positive
cells. In the assay of peritoneal macrophages, the LDH
level that was elevated by L. pneumophila was decreased
by pretreatment with CA074Me (Figure 5B).
Discussion
In this paper, we studied cell death induced by L. pneu-
mophila in macrophages and compared this death with
that induced by an apoptotic agent. A high dose of
L. pneumophila induced necrotic cell death in which
cathepsin B played an important role in determination
of the mechanism of cell death. This study reveals a
novel aspect of the pathogenesis of Legionnaires’ disease
and identifies potential novel therapeutic targets for the
regulation of inflammation.
Research regarding the mechanism of cell death related
to L. pneumophila infection has focused mainly on apop-
tosis induced in monocytic cell lines or in murine macro-
phages with using a low dose of bacteria, such as an MOI
50 or lower [7,9]. On the other hand, Husmann and
Johnson reported that infection with high multiplicity of
L. pneumophila induce cytotoxicity in guinea pig perito-
neal macrophages [20]. Similarly, the same dose in this
study also induced necrotic cell death in mouse bone-
marrow derived macrophages [11]. However, mechan-
isms of necrotic cell death were not determined.
Apoptosis is generally recognized as a non-inflammation-
producing cell death [3], however, serious inflammation is
Figure 2 L. pneumophila-induced THP-1 cell death is cathepsin B-dependent. (A) Western blot analysis of pro-cathepsin B expression
following stimulation with an MOI of 500 of L. pneumonia for the indicated times. (B) The effect of the specific cathepsin B inhibitor, CA074Me,
on the L. pneumophila -induced LDH. CA074Me inhibited L. pneumophila-induced cytotoxicity at concentrations greater than 50 μM. (C) The
microscopic findings after pretreatment with CA074Me (100 μM) on L. pneumophila-induced necrotic cells. The top scale bar represents 50 μm
and the bottom represents 20 μm. (D) The effect of CA074 pretreatment on L. pneumophila-induced elevation of HMGB-1. Error bars in (B) and
(D) represent means ± SD. ** indicates p < 0.01.
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morphological features. The percentage of necrotic cells was significantly decreased by pretreatment with CA074. (B) Annexin V and PI stained
cells were evaluated by flow cytometry analysis 6 h after stimulation with L. pneumophila. The percentage of stained cells is indicated at the
bottom of each panel. (C) Morphological classification of MG132-treated cells. MG132 induced-apoptotic cells were inhibited by pretreatment
with CA074Me. (D) Flow cytometric analysis of MG132-treated cells stained with Annexin V and PI at 6 h. Values are expressed as means ± SD.
** indicates p < 0.01.
Figure 4 L. pneumophila-induced high activation of cathepsin B is involved in PARP cleavage and cell death.( A )T h ea c t i v i t yo f
cathepsin B in cell lysates after L. pneumophila (MOI of 500) or MG132 treatment was measured. L. pneumophila rapidly and strongly enhanced
cathepsin B activation. In contrast, MG132 gradually activated cathepsin B over the time of assay. Data are representative of three independent
experiments. (B) Effects of CA074Me and a pan-caspase inhibitor (zVADfmk, 100 μM) on PARP cleavage after L. pneumophila or MG132 treatment
at 2 h, assessed by western blot. L. pneumophila-induced PARP cleavage was attenuated by CA074Me but not by zVADfmk. In contrast, zVADfmk
showed mild inhibition of MG132-induced PARP cleavage. Cont; control, zV; zVADfmk, CA; CA074Me. (C) Effects of CA074Me and zVADfmk on
the cytotoxicity of L. pneumophila-treated cells. CA074Me, but not zVADfmk, significantly decreased L. pneumophila-induced LDH. Values are
expressed as means ± SD. ** indicates p < 0.01.
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Since necrosis is known to induce inflammation, necrosis
could potentially be involved in the pathogenesis of
Legionnaires’ disease. Necrotic cells appeared even after
the treatment with a low dose of bacteria as shown in Fig-
ure 1D, and necrotic cells increased HMGB-1. Thus, the
mixed type of cell death can be involved in the pathogen-
esis of Legionnaires’ disease.
Apoptosis is a major programmed cell death and its
signaling pathways and inducers have been well studied
[21,22]. There is some evidence that necrosis, like apop-
tosis, is regulated by several enzymes [23] such as lyso-
somal enzymes, cathepsins [24]. For instance, cathepsin
B mediates apoptosis induced by TRAIL in oral cancer
cells [25] and necrosis induced by nigericin in THP-1
cells [26]. In this study, cathepsin B also regulated both
apoptotic and necrotic cell death.
Thus, cathepsin B is a non-caspase protease that can
lead to apoptosis and necrosis. However, the mechanis-
tic details of cathepsin B involvement in each type of
cell death are still uncertain. The type of cell death
mediated by lysosomal enzymes appears to depend on
the magnitude of lysosomal permeabilization and the
consequent release of lysosomal enzymes into the cyto-
sol. Thus, the massive release of enzymes after complete
lysosomal permeabilization induces necrotic cell death,
whereas partial permeabilization with the release of
lower levels of enzymes leads to apoptotic cell death
[14]. L. pneumophila-induced high cathepsin B activity
would support the possibility that complete lysosomal
permeabilization had occurred, resulting in necrotic cell
death. However, as pretreatment with CA074Me showed
incomplete inhibition of cell death, reactive oxygen spe-
cies [27] and multiple proteases such as calpains [28]
and other cathepsins [29,30] may be involved in
L. pneumophila-induced necrotic cell death by cross-
talking.
Recently, several cell death pathways have been newly
identified. Pyroptosis is a caspase-1-dependent cell death
and results in releasing inflammatory cytokines such as
IL-1b and IL-18 [31]. It is reported that L. pneumophila
induces pyroptosis [32,33]. Pyroptosis features plasma
membrane permeability and nuclear condensation, how-
ever, cells in this study showed poor-stained nuclei
which is mismatched to pyroptosis. In addition, in pre-
screening of inhibitory effect of cell death in this study,
a specific caspase-1 inhibitor, zYVADcmk, had no effect
on the LDH release (data not shown). Necroptosis or
programmed necrosis, another type of cell death, is a
necrotic cell death which is executed by enzymatic regu-
lation such as receptor-interacting protein kinase 1, cal-
pains and cathepsins [23]. The cell death in this study
showed necrotic feature and cytotoxicity induced by
L. pneumophila was independent of caspases including
caspase-1 but dependent of cathepsin B, suggesting that
the cell death in this study was consistent with necrop-
tosis rather than pyroptosis. However, our results with
the immortalized cell line may need to be interpreted
with caution in terms of cell death phenotypes as the
immortalization process can affect cell death pathways.
In the cell death in the host response to L. pneumo-
phila infection, flagellin is an important bacterial com-
ponent as an inducer of pyroptosis [32]. Pyroptosis is
also observed during Salmonella [34] or Shigella [35]
Figure 5 Cathepsin B is involved in L. pneumophila-induced murine macrophage death (A) Macrophages derived from the
bronchoalveolar or peritoneal lavage fluid of A/J mice were stimulated with an MOI 500 of L. pneumophila for 6 h followed by staining with
Hoechst 33342 and PI. The PI-positive cells (red) represent necrotic cells. L. pneumophila infection increased, and pretreatment with CA074Me
decreased, the number of PI-positive cells. The scale bar represents 75 μm. (B) LDH release 6 h after L. pneumophila-infection in peritoneal
macrophages. CA074Me pretreatment had an inhibitory effect on L. pneumophila-induced cytotoxicity. Values are expressed as means ± SD.
** indicates p < 0.01.
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death pathways are different in these bacteria. Since we
did not rule out the possibility of the involvement of fla-
gellin and other components, we need further examina-
tion to reveal the relationship between bacterial
components and cell death.
Cleaved PARP has been widely employed as a useful
hallmark of apoptosis because PARP is processed by
caspases [36]. However, L. pneumophila induced necro-
tic cell death in this study was accompanied by cleavage
of PARP. This conflicting result can be attributed to
excessive cathepsin B activation because PARP can be
processed not only by caspases but also by cathepsin B
and other proteases such as calpain, granzyme B and
cathepsin G [18,37]. Indeed, L. pneumophila-induced
cleaved PARP was attenuated by a cathepsin B inhibitor
but not by a pan-caspase inhibitor, and the necrotic fea-
tures of the cells were probably caused by indiscriminate
degradation of cellular components by cathepsin B.
For the treatment of serious infectious diseases, it is
important to regulate excessive inflammation. HMGB-1
is a cytokine that mediates strong systemic inflammatory
responses, activates prototypical inflammatory responses
in immune cells [38], and clinically causes acute lung
injury [39]. Sepsis is a major example of severe inflam-
matory disease in which a vicious cycle involving
HMGB-1 is implicated and elevated serum levels of
HMGB-1 correlate with a worse prognosis in patients
with sepsis [40]. Because severe cases of Legionnaires’
disease can occur against which antibiotic therapy alone
is insufficient even using antibiotics with high antibac-
terial activities [41], this excessive inflammation invol-
ving HMGB-1 induced by L. pneumophila is associated
with the severity of the pathogenesis. Although further
examination is necessary to determine whether inhibi-
tion of necrosis is actually beneficial for the treatment
of Legionnaires’ disease, the programmed necrosis
induced by L. pneumophila that is described in this
study may provide new information for the identifica-
tion of therapeutic targets.
In conclusion, we report that a high dose of L. pneumo-
phila induces cathepsin B-dependent necrosis in macro-
phages and that HMGB-1 release was also regulated by
inhibition of necrotic cell death. The pattern of cathepsin
B activation was important for subsequent PARP clea-
vage and the type of cell death. Necrotic cell death can
contribute to the pathogenesis of Legionnaires’ disease
and its severity and regulation of this cell death may pro-
vide some benefit in treatment of this disease.
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